SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019023
Filing Date
2023-11-14
Accepted
2023-11-14 16:10:21
Documents
14
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20231114x8k.htm   iXBRL 8-K 37326
2 EX-99.1 aytu-20231114xex99d1.htm EX-99.1 269277
3 GRAPHIC aytu-20231114xex99d1001.jpg GRAPHIC 4381
  Complete submission text file 0001558370-23-019023.txt   452387

Data Files

Seq Description Document Type Size
4 EX-101.SCH aytu-20231114.xsd EX-101.SCH 3132
5 EX-101.LAB aytu-20231114_lab.xml EX-101.LAB 15904
6 EX-101.PRE aytu-20231114_pre.xml EX-101.PRE 10061
8 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20231114x8k_htm.xml XML 4910
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 231406188
SIC: 2834 Pharmaceutical Preparations